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Gastrointestinal symptoms are frequent in the adult working-age population. Sufferers 
often relate them to ingested food substances, especially cow’s milk. The purpose of this 
study was to evaluate subjective food-related gastrointestinal symptoms and their relation 
to cow’s milk. This was done by determining the genotype of adult-type hypolactasia, 
measuring antibodies against milk protein, and screening the most common cause for 
secondary hypolactasia, namely coeliac disease, in adults in primary care. The aim was 
also to evaluate the clinical role of the laboratory tests used in the study. 
The whole study group comprised 1900 adults who gave a blood sample for the study 
when they attended a health care centre laboratory for various reasons. Of these 1885 
completed a questionnaire on food-related gastrointestinal symptoms. The response rate 
was 99%, which is exceptionally high. 
Study No. I evaluated the prevalence of adult-type hypolactasia and its correlation to 
self-reported milk induced gastrointestinal symptoms. The questionnaires requested data 
on dairy consumption and abdominal symptoms. The testing for hypolactasia was done by 
determination of the C/T-13910 genotypes of the study subjects. The results show that 
patients with the C/C-13910 genotype associated with adult type hypolactasia consume less 
milk than those with C/T-13910 and T/T-13910 genotypes (high lactase activity).  
 Study No. II evaluated the prevalence and clinical characteristics of undiagnosed 
coeliac disease in the whole study population with transglutaminase and endomysium 
antibodies and their correlation with gastrointestinal symptoms. The prevalence of 
undiagnosed coeliac disease was 2%, which is surprisingly high. Serum transglutaminase 
and endomysium antibodies are valuable tools for recognising an undiagnosed coeliac 
disease and should be used in outpatient clinics for diagnosing gastrointestinal symptoms. 
In the study No. III the evaluation of milk protein IgE related hypersensitivity was 
carried out by stratifying all 756 study subjects with milk related problems and randomly 
choosing 100 age and sex matched controls with no such symptoms from the rest of the 
original study group.  
In the study No. IV 400 serum samples were randomly selected for analyzing milk 
protein related IgA and IgG antibodies and their correlation to milk related GI-symptoms. 
The measurement of milk protein IgA, IgE or IgG (studies No. III and IV) did not 
correlate clearly to milk induced symptoms and gave no clinically significant information; 
hence their measurement is not encouraged in outpatient clinics. 
In conclusion, this large study of milk-related gastrointestinal symptoms in adults 
shows that GI-symptoms are subjectively very common. Adult type hypolactasia is often 
considered the reason for them, and determination of the C/T-13910 genotypes is a practical 
way of diagnosing the possibility of adult type hypolactasia in an outpatient setting. 
Undiagnosed coeliac disease, the possible cause of secondary hypolactasia, should be 
actively screened and diagnosed in order to apply a gluten free diet and avoid the GI-
symptoms and nutritional deficiencies. Cow’s milk hypersensitivity in the adult population 






Measuring of cow’s milk protein specific antibodies IgE, IgA or IgG do not correlate with 
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ARA Reticulin antibody  
AGA             Gliadin antibody 
BHT Breath hydrogen test 
BMI Body mass index 
CD Coeliac disease 
CMA Cow`s milk allergy 
DGP Deamidated gliadin peptide 
DNA Deoxyribonucleic acid 
EmA Endomysium antibody of IgA class 
GI Gastrointestinal 
HLA Human Leukocyte Antigen 
IBS Irritable bowel syndrome 
IgA Immunoglobulin A 
IgE Immunoglobulin E 
IgG Immunoglobulin G 
IgM Immunoglobulin M 
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LTT Lactose tolerance test 
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C/T Cytosine/Thymidine 
PCR Polymerase chain reaction 
RAST Radioallergosorbent test 
S-TfR Serum transferrin receptor  
T/T Thymidine/Thymidine 
tTG-ab Tissue transglutaminase antibody 







According to clinical experience in outpatient clinics, it is common for attenders to suspect 
various food-related reasons as being causative of their gastrointestinal symptoms. It is 
often a challenge for a physician to diagnose the origin of these symptoms. The symptoms 
do not normally cause absence from work, but can reduce working capacity by causing 
inconvenience and lack of concentration. 
Cow’s milk, and especially lactose, is more often considered to be the reason for 
gastrointestinal symptoms than true lactose malabsorption (Caroccio et al 1998; Vesa et al 
2000). This is very important since milk consumption in Finland per capita is high; in 
2007, this was 3.76 dl/ person/ day, and if we include yoghurt and sour milk-products the 
consumption was 5.05 dl/person/day. Ice-cream consumption was 0.36 dl/person/day 
(www.maitojaterveys.fi). Hence the true correlation of GI-symptoms with ingested milk is 
most meaningful. 
The bases of this study were to test the newly implemented C/T-13910 genotype–
determination in clinical practice in the adult population; its correlation to milk induced 
gastrointestinal problems: and its applicability for testing of adult-type hypolactasia in 
primary care.The aim was also to clarify possible confounding factors such as allergy to 
milk protein, and coeliac disease, which is the major cause of secondary hypolactasia.   
This study is the first large-scale study performed among the working age adult 
population in this area of Finland, and the perspective is clinically orientated. 
A thorough questionnaire on food- and especially milk-related GI-problems was 
generated and pretested. Four healthcare centres in Espoo city and the outpatient clinic of 
the Military Hospital Tilkka agreed to take part in the study. The approval of the Ethical 
Committee was granted in December 2003 and the study started in February 2004. In a 
three-month period, 1900 volunteers gave a blood sample for the study when visiting the 
outpatient laboratory for various reasons. Of these, 99% completed the questionnaire. 
The questionnaires were analyzed and four different types of research approaches were 
generated:  
1. C/C-13910 genotype-testing related to self-experienced symptoms of hypolactasia 
2. Undiagnosed coeliac disease; its prevalence and correlation to clinical symptoms 
3. The role of cow’s milk protein IgE in milk hypersensitivity in adults 
4. The role of cow’s milk protein IgG and IgA in milk hypersensitivity in adults. 
All serum samples were also tested for Helicobacter pylori antibodies, and the possible 
role of Helicobacter pylori infection in nonspecific gastrointestinal symptoms resembling 











2 Review of the literature 
2.1 Adult-type hypolactasia  
2.1.1 History and clinical manifestations 
In primary adult-type hypolactasia, lactase activity is high at birth and gradually decreases 
during childhood and adolescence. Primary hypolactasia is also called lactase 
nonpersistence and is a normal physiologic phenomenon among mammals. For newborns, 
milk is a valuable nutritional source, but its importance diminishes after weaning. There 
are also other types of lactase deficiencies and the terminology is clarified in Table 1 
below. 
 
Table 1      Terminology of lactase deficiencies. 
  
Lactose intolerance symptoms from lactose 
Hypolactasia very low lactase activity 
Alactasia or lactase deficiency total lack of lactase activity 
Lactose malabsorption or lactose 
maldigestion 
poor lactose hydrolysing capacity 
Primary lactose malabsorption or lactase 
non-persistence or adult-type 
hypolactasia             
manifestation during development, 
irreversible 
Secondary lactose malabsorption due to mucosal injury, reversible 
Congenital lactase deficiency manifestation immediately after birth, 




Gene mutation of high lactase activity is thought to coincide with the development of 
dairying within the last ten thousand years, hence being a relatively new evolutional 
development and explaining the higher prevalence of lactase persistence in Northern and 
Central Europe, America and Australia (Flatz et al 1987). In Finland the prevalence of 
primary lactose maldigestion is 17%, whereas in Central Asia it is 90-100% (Sahi 1994). 
Ethnicity seems to have an influence in which age lactase activity degrades: in the Thai 
population, with almost 100% having adult-type hypolactasia, the average age of losing 






2000; Rasinperä et al 2005; Seppo et al 2008). The factors responsible for this activity 
degradation are not yet known. The lactase activity is not sustained even when the milk 
consumption would be continued (Schrimshaw et al 1988). 
Lactase, or more precisely lactase-phlorizin hydrolase, is needed for hydrolyzing milk 
sugar lactose to galactose and glucose in the brush-border membrane of the small 
intestinal epithelium, after which they can be absorbed. Without lactase-phlorizin, 
hydrolase lactose cannot be absorbed and causes symptoms such as bloating, flatulence 
and diarrhoea in the majority of subjects. There are, however, considerable individual 
variations in the symptoms due to differences of microbial flora of the colon and 
sensitivity to stretching of the mucosal membrane, as well as to the amount of lactose 
consumed (Vesa  et al 1998; Egert et al 2006).  
     Subjects with low lactase activity and gastrointestinal symptoms often have a better 
quality of life if they reduce their milk consumption or use delact milk. But milk is often 
unjustifiedly considered the reason for the GI-symptoms and self-diagnoses of “milk 
intolerance” are common. Milk and other dairy products are a valuable source of calcium, 
which is needed especially for the construction of bones. Hence the use of milk should not 
be discouraged among children and adolescents without sound reasons (Seppo et al 2006).  
A quick and easily accessible genotype test is therefore valuable in clinical practice. 
Furthermore, it is not known whether lactose consumption is harmful for people with 
genetic hypolactasia. Indirect evidence shows that there might be certain areas of 
increased risk. Studies concentrating on the possible risk of cancer have shown no definite 
increased risk of ovarian (Kuokkanen et al 2005), prostate (Torniainen et al 2007) or colon 
cancer (Rasinperä et al 2005) in the lactase non-persistent subjects. However, colon cancer 
needs further studies since in the Finnish study population there was statistically a 
significantly increased risk of colon cancer, yet in the Spanish or British study populations 
this was not the case (Rasinperä et al 2005).  
 
2.1.2 Diagnosing adult type hypolactasia 
The number of individuals suspected of having lactose intolerance is higher than the true 
prevalence of adult type hypolactasia (Jussila et al 1969; Johnson 1993; Vesa et al 1996; 
Caroccio et al 1998; Saltzman et al 1999; de Vrese et al 2001). Symptoms vary greatly in 
severity and depend on the amount of lactose ingested and on individual sensitivity, and 
may overlap with those of other gastrointestinal diseases such as IBS or diseases 
presenting with secondary lactose malabsorption i.e. coeliac disease or infection of the 
small intestine (Tamm 1994). It has been shown that lactose-restricted diets improve 
symptoms markedly, for example in irritable bowel syndrome (IBS) patients with primary 
lactose malabsorption, and reduce the number of visits to outpatient clinics (Bohmer 
2001). Accurate diagnosis of adult-type hypolactasia, which is easily treatable by diet 






Diagnosis of adult-type hypolactasia has been based on indirect methods, the lactose 
tolerance test (LTT) or breath hydrogen test (BHT). These methods are time-consuming 
for the patients and need substantial assistance by medical personnel. Their sensitivity and 
specificity are not sufficient due to multiple factors affecting the results. 
 LTT is based on the measurement of the increase in blood glucose level after a 50 g 
oral lactose load. Blood samples are then taken at intervals of 20, 40 and 60 minutes. The 
time spent on collecting the blood samples is sometimes extended up to 120 min 
(Newcomer et al 1975). A blood glucose rise above 1.1 mmol/l is considered normal. 
Delayed gastric emptying can cause false positive results (Kern et al 1966; Newcomer et 
al 1966). LTT is also not reliable in diabetics (Lerch et al 1991). Furthermore, a variety of 
hormonal influences may have an effect on the result (Solomons 1981). Specificity of the 
LTT ranges from 77% to 96%, and sensitivity from 76% to 94% (Arola 1994). 
BHT is based on the determination of hydrogen from expired air after an oral lactose dose 
of 50 g. Samples are taken at zero, and then at intervals of 15 to 60 min for 2 to 6 hours 
(Solomons 1981). Colonic flora has a crucial role since hydrogen production takes place in 
the colon and 14-21 % of the hydrogen produced is exhaled through the lungs (Levitt 
1969). False negative breath hydrogen determinations can be detected in a fall of colonic 
pH and in active diarrhoea (Bond et al 1972; Perman et al 1981). Specificity of BHT 
varies from 89% to 100% and sensitivity from 69% to 100% (Arola 1994). 
    The gold standard of diagnosing adult-type hypolactasia, the invasive disaccharidase 
determination method requiring a jejunal biopsy, is not suitable for everyday clinical 
practice (Dahlqvist 1984). 
Adult-type hypolactasia was shown in 1973 to be inherited as an autosomal recessive 
trait (Sahi et al 1973), and in 2002 a single nucleotide polymorphism C to T change 13910 
base pairs from the 5’end of lactase gene trait in chromosome 2 was identified to associate 
with the lactase persistence/nonpersistence trait (Enattah et al 2002).  Analyses of several 
hundred intestinal biopsies have demonstrated that the C/C-13910 genotype is associated 
with low lactase activity (<10 U/g/protein) and the C/T-13910- and T/T-13910 genotypes with 
high activity (Enattah et al 2002; Kuokkanen et al 2003; Rasinperä et al 2004; Enattah et 
al 2008). In 2002 a commercial kit using this gene technology was applied in clinical 
practice (HUS-lab) and became available in primary care units. Since the test is based on 
molecular genetics, the result is valid lifelong and does not need to be repeated. However, 
only approximately 70% of the subjects having adult-type hypolactasia experience 
symptoms from lactose and 30% of subjects do not experience any symptoms from 
ingested lactose. (Carroccio et al 1998) Furthermore, in Finnish children the activity of 
lactase-phlorizin hydrolase does not on average decrease before school age; hence the test 
should be used with precaution in young children; but in the working-age population it 
gives valid information on the C/T-13910 genotype as a possible reason for lactose induced 







2.2 Coeliac disease 
2.2.1 History and clinical manifestations 
Coeliac disease is a life-long autoimmune based entheropathy. Its history has been 
described since the second century B.C. (Aretaios). In the late nineteenth century the 
disease was described as a chronic indigestion resulting in loose stools, cachexia and 
distended abdomen. In 1952 a Dutch paediatrician, Dicke, discovered the harmful effects 
of barley, rye and wheat in coeliac disease, and as a result van de Kamer with his 
collegues conceived a strict gluten-free diet for the treatment of the condition. Paulley 
revealed in 1954 that small-bowel mucosal damage indicated coeliac disease, and a 
peroral apparatus for obtaining an intestinal biopsy for correctly diagnosing the disease 
was invented by Shiner in 1957. New, easier diagnostic methods have been applied for the 
screening of coeliac disease, yet the actual diagnosis is still based on intestinal biopsy.  
In 1969 Van de Meer and Reunala with his colleagues revealed that coeliac disease is 
not only an intestinal disease but also has other extra-intestinal manifestations i.e. 
dermatitis herpetiformis (Van de Meer 1969; Reunala et al 1977). Later it was discovered 
that the disorder can also be asymptomatic or present only with mild forms of abdominal 
complaints or anaemia, tiredness and weight loss (Pare et al 1988; Corazza et al 1994; 
Mustalahti et al 1999; Tursi et al 2001; Green 2005; Haapalahti et al 2005). Isolated, 
subclinical malabsorption of iron, folic acid, calcium, vitamin D or B12 can also be 
present (Bode et al 1996; Kemppainen et al 1998; Dahele et al 2001; Kupper 2005). 
Neurological symptoms, reproductive disorders and an increased risk of malignancies, 
especially non-Hodgkin’s lymphoma, have been described in connection with coeliac 
disease (Green et al 2003; Viljamaa et al 2006) 
In clinically manifesting coeliac disease there is usually a secondary lactose 
malabsorption due to damage of the mucous villous system of the small intestinal 
membrane. 
 
2.2.2 Diagnosing coeliac disease 
Coeliac disease results from the interaction between genetic, environmental and immune 
factors.  Gluten, found in barley, wheat and rye is necessary for igniting the disease. 
Genetic factors play an important role as the prevalence of coeliac disease is 11,5% among 
relatives of coeliac disease patients.  
The correct diagnosis of coeliac disease in the early course of a symptomatic disease is 
important since the subtotal villous atrophy may cause nutritional deficiencies besides the 
gastrointestinal symptoms, with a reduction in the quality of life (Kemppainen et al 1998; 
Fabiani et al 2000; Howard et al 2002). In recent years the prevalence of undiagnosed 
coeliac disease is thought to be as high as 1:80 (Johnston et al 1997; Kolho et al 1998; 






Used in clinical practice for over fifty years, the intestinal biopsy is still the gold 
standard for diagnosing coeliac disease. A subtotal villous atrophy and crypt hyperplasia 
seen in the specimen are mandatory in settling the diagnosis (Interlaken criteria). 
Furthermore, T cells infiltration of the lamina propria, along with an increase in the 
number of intra-epithelial lymphocytes is a typical histological finding in coeliac disease 
(Silano et al 2009). An intestinal biopsy proceeded with a gastroscope is inconvenient for 
the patient and needs a specialist as well as assistant personnel to perform; hence the costs 
are also high. The non-invasive coeliac antibody tests have proved to be valuable in 
screening for coeliac disease and evaluating the need for villous biopsy. Additionally, the 
antibody test can be used in the guiding of dietary compliance (Sulkanen et al 1998; Collin 
et al 2002; West et al 2003). However, a jejunal biopsy should always be used for 
diagnosis when the symptoms are severe, even if the antibody tests are negative. The 
differential diagnosis to other mild forms of villous destructing conditions eg. infections of 
the jejunum or a specific food allergy is not always easy, and the specific serum antibodies 
for coeliac disease are useful in confirming the diagnosis. 
The coeliac antibodies are produced in untreated disease in the intestinal mucosa  
(Marzari et al 2001). The production of antibodies additionally results in coeliac disease-
specific antibodies in the circulation. The antibodies are mainly of IgA-class. Of these, the 
autoantibodies i.e. reticulin antibody (ARA), endomysium antibody (EMAb) and tissue 
transglutaminase antibody (tTG-ab) are formed against the patient’s own tissue structures, 
endogenous antigens. Endomysium, literally meaning within the muscle, is a layer of 
connective tissue that ensheaths a muscle fibre and is mostly composed of reticular fibres 
and has specific endomysium antigens. tTG is a calcium-dependent enzyme and has 
specific antigens. It is stored mainly intracellularly and released to extracellular space 
upon mechanical and inflammatory stress (Bergamini et al 1999). EMAb and tTG-ab are 
presently used in clinical practice. These antibodies should always be measured together 
with serum IgA, since false-negative results can be obtained in patients with selective IgA 
deficiency (Collin et al 1992; Cataldo et al 1998). The EMAb test is based on 
immunofluorecence giving a qualitative result (Ladinser et al 1994), where as tTG-ab is 
based on a quantitative result with ELISA (Dietrich et al 1997). 
In clinical laboratory practice, human umbilical cord is currently used as an antigen. 
The sensitivity of IgA-class EmAb test varies from 75% to 100%, but in most studies is 
above 92%. Specificity varies accordingly, but is in most studies close to 98%. The 
sensitivity of IgA-class tTG-ab is above 90 % in the majority of studies published and 
specificity 95-100% (Salmi T 2006). In patients with selective IgA deficiency the IgG-
class coeliac antibodies (S-EMAbG and S-tTGAbG) are used in clinical practice 
(www.yhtyneetlaboratoriot.fi). Their sensitivity and specificity are almost similar to IgA-
class antibodies (Collin et al 1992; Cataldo et al 1998). The sensitivity and specificity of 
these antibody tests varies according to the transglutaminase protein, which is used as an 
antigen. It is most important to have a profound knowledge of the commercial antigen 
product used since the test result can vary accordingly. A new rapid test for coeliac 
disease, based on Finnish-Hungarian innovation, can even be used at home. The test kit is 
easy to use and the clinical accuracy is similar to the conventional antibody-based tests 






Coeliac patients must have an HLADQ2 or DQ8; however, these two genotypes are 
necessary but not sufficient for coeliac disease since 40 % of healthy Caucasians have 
these same heterodimers (Mäki et al 2003). Thus, the HLA genotyping is not used in 
normal clinical practice when diagnosing coeliac disease. 
ARA or gliadin antibodies (AGA) are no longer used in clinical practice due to their 
low sensitivity and specificity. However, the new deamidated gliadin peptide (DGP) 




2.3 Hypersensitivity to milk protein 
2.3.1 History and clinical manifestations 
Adverse reactions to food are classified as non-immune mediated food intolerance or 
immune mediated food hypersensitivity (Bruijnzeel-Koomen et al 1995). Food 
hypersensitivity or food allergy is triggered by an aberrant immune response caused by 
ingestion of dietary antigens. Allergic reactions are traditionally classified under four 
types of hypersensitivity reactions (Britton et al 2002; Male et al 2002). More than one 
mechanism may be involved in allergic reactions, but the most plausible mechanisms are 
IgE mediated (Type I) immediate anaphylactic reactions. Antibody-dependent cytotoxic 
(Type II) hypersensitivity is an important part of the body’s normal humoral immune 
response (Male 2002). In this type of hypersensitivity, IgG and IgM antibodies identify 
cell-surface antigens and activate the complement system and damage the cell. Immune-
complex-mediated (Type III) hypersensitvity is an effector-cell and complement mediated 
tissue damage (Hay et al 2002). Delayed cell-mediated (Type IV) hypersensitivity reaction 
takes more than 12 hours to develop (Britton 2002). In a Type IV reaction, T cells identify 
antigens after which they produce cytokines and other soluble factors and hence mediate 
the hypersensitivity reaction. It is not known, whether all four types of reactions are 












Figure 1  Different types of  food  hypersensitivity 
 
 





























The symptoms of food allergy may appear in the skin, in subcutaneous tissue, in the 
GI-system or in the respiratory tract. Typical cutaneous symptoms of food hypersensitivity 
are rash, urticaria, atopic dermatitis and, more seldom, angio-oedematic reaction. Typical 
gastrointestinal symptoms are diarrhoea, pain and vomiting. Asthmatic, eye and nasal 
symptoms also do exist (Nermes et al 2009). 
Cow’s milk allergy (CMA) is IgE mediated in 57-64% of allergic infants under the age 
of one year (Vanto et al 1999; Saarinen et al 2000). The majority of paediatric patients 
have symptoms from more than one organ system: 50-60% have cutaneous, 50-60% 
gastrointestinal and 20-30% respiratory symptoms (Host 2002). However, the prognosis of 
CMA in infancy is good with a remission rate of 85-90% by the age of three (Host et al 
































1990; Saarinen et al 2005). In infancy, the non-IgE mediated delayed type reactions to 
cow’s milk recover the quickest (Vanto et al 2004). 
CMA in school-aged children and adults is not IgE mediated but more like a new form 
of delayed-type gastrointestinal cow’s milk hypersensitivity, also known as cow’s milk 
entheropathy (Bengtsson et al 1997; Ulanova et al 2000; Kokkonen et al 2001). The 
mucosal changes in cow’s milk enteropathy are clearly different of those in coeliac disease 
(Kokkonen et al 2001; Turunen et al 2004) or small children with food allergy. 
The study among young Finnish adults showed a high serum reactivity to milk protein 
in subjects clinically nontolerant to milk but with normal lactose tolerance (Pelto et al 
1998), and this finding was confirmed in a larger study (Pelto et al 1999) implying that 
serum reactivity, i.e. capacity of antigen-antibody complexes to activate phagocytes, may 
have a role in adult milk hypersensitivity. Only occasional case reports of IgE-mediated 
cow’s milk allergy in adulthood exist. 
2.3.2 Diagnosing cow’s milk allergy 
No single laboratory test is diagnostic for either delayed- or immediate- type of cow’s 
milk allergy. Hence, the diagnosis is still based on strict elimination and challenge 
procedures. In patients with delayed reactions, a placebo-controlled food challenge would 
be the most reliable method, but it is clinically not practical (Bindslev-Jensen et al 2004). 
Especially in adults, the main gastrointestinal symptoms of cow’s milk hypersensitivity 
are difficult to distinguish from the ones caused by primary or secondary hypolactasia. 
       Patients suffering from IBS often relate their GI-symptoms to milk (Hillilä et al 
2007). Dyspepsias can also be related to milk (Pajala et al 2005), either to hypolactasia or 
hypersensitivity to milk. Zuo et al 2007 in China studied serum food antigen-specific IgG 
and IgE antibodies in patients suffering either from IBS or functional dyspepsia (FD), 
comparing them to the group of healthy controls. They found no difference in the titres of 
food specific IgE antibodies between the groups. The serum food specific IgG antibody 
titres were higher among the subjects belonging either to the FD- or IBS-group compared 
to the healthy controls, but there was no correlation between the titre level of the antibody 
and the symptom severity (Zuo et al 2007). 
In early infancy the presence of a specific elevation of IgE antibodies to cow’s milk 
and either a skin prick or patch test for cow’s milk may be diagnostically valuable. Skin 
prick or patch tests and milk protein IgE are rarely useful in adults (Norgaard et al 1992). 
The roles of food specific and especially milk specific IgG and IgA are currently being 






3 Aims of the study 
The aims of this study were: 
 
To study the prevalence of milk-related symptoms among patients with C/T-13910 
genotypes and the usefulness of the genetic test of adult-type hypolactasia in primary 
health care 
  
     To evaluate undiagnosed coeliac disease, the most common cause of secondary   
hypolactasia; its prevalence and correlation to clinical symptoms. 
 
     To clarify hypersensitivity to milk protein; the role of cow’s milk protein IgE    
     in adults. 
 
     To assess the role of cow’s milk protein IgG and IgA in milk hypersensitivity   







4 Subjects and methods 
4.1 Study subjects 
4.1.1 Study No. I: C/T-13910   genotype-testing  
This study included 1900 working age adults (18-64 years) from the capital area of 
Finland, who visited a health care centre laboratory for different reasons in spring 2004. 
Four different health care centres in the city of Espoo and the outpatient clinic of the 
Military Hospital Tilkka took part in the study. The targeted size for the study was 2000 
subjects, but due to understaffed laboratory personnel the study was ended prematurely 
with only 1900 subjects. The decision was made not to continue the study later (after the 
summer holidays) in order to minimize the seasonal variation on the study results.  All the 
samples and questionnaires were collected in a three-month period from February to May 
2004. 
 An information brochure about the study was put up on the walls of the laboratory 
waiting room. The questionnaires and the written consent forms were available in the 
waiting room, and the patients were advised to fill in the questionnaires while waiting for 
a laboratory test. The volunteers completed a questionnaire on gastrointestinal symptoms 
and consumption of dairy products. The laboratory personnel provided verbal information  
about the study, took the blood samples and collected the written consent forms together 
with the questionnaires. The blood samples were sent for analysis to the study laboratory 
of the University Hospital in Helsinki. The questionnaires were collected weekly by the 
dissertee. The answers to the questionnaires were put into Excel format, after which they 
were statistically analysed. 
Of the total study group, 21% of the subjects belonged to the youngest age group of 
18-35 years, 34 % were aged 36-51 years and 45 % 52-64 years. 73% of the participants 










































Age distribution   
 18-35 years 
 36-51 years 














Questionnaires completed  505 (99) 1380 (99) 1885 (99) 
 











133 (26) 623 (45) 756 (40) 
Food-related GI-symptoms 
 
254 (50) 926 (67) 1180 (62) 
Laboratory visit 
 Health check-up (or other reason) 
 Abdominal complaints 
 Nongastro-intestinal disease 


















Drinking milk n (%) 
 Yes 
 No 





















4.1.2 Study No. II: undiagnosed coeliac disease and its clinical symptoms 
For this study, we included the serum samples of the total cohort of 1900 subjects. The 
samples were screened for coeliac disease and the answers to the questionnaires evaluated 
accordingly. The subjects with an elevated serum transglutaminase and endomysium 
antibody titres, and hence considered as possibly having undiagnosed coeliac disease, 
were contacted by phone and requested to have a gastroscopy done if possible. The 
telephone interview also included a questionnaire of possible gastrointestinal symptoms 
related to cereal, the presence of coeliac disease in close relatives and other coexistent 
diseases of the study subjects. The results of the gastroscopies and biopsy samples were 
also accordingly requested by phone. 
 
4.1.3 Study No. III: the role of cow`s milk protein IgE in adults 
This study included all 756 participants of the original study group of 1900 patients 
attending the laboratory who reported suffering from milk-related gastrointestinal 
problems. A control group of 101 subjects was randomly selected from those reporting no 
milk-related symptoms (n=638). Of the 1885 participants returning the questionnaire, 491 
did not answer the question on milk-related gastrointestinal symptoms and were excluded 
from the selection. 
4.1.4 Study No. IV: the role of cow’s milk proteins IgG and IgA in milk 
hypersensitivity in adults 
For this study, 400 subjects (198 women and 202 men) were randomly selected from a 
total of 1900 adults attending laboratory investigations in primary care. All participants 
had completed a questionnaire on abdominal symptoms and dairy consumption. Twelve 
samples were excluded due to insufficient amount of sera. Thus, the study group 
comprised 388 adults (aged 18-64 years, mean age 40 years) of whom 119 reported 




4.2.1 Questionnaires  
All 1900 participants were given a questionnaire to complete while waiting for the 
laboratory, or immediately after the blood sample had been taken. 1885 questionnaires 
were returned (99%). Each participant provided their name, address, social security 






symptoms; a check-up due to a previously diagnosed disease; health check-up; other 
reason). They were asked whether they had had gastrointestinal symptoms in the previous 
three months and during the preceding week, and if they suspected the symptoms to be 
related to food and especially to milk ingestion. We also enquired their consumption of 
dairy products and the different types of dairy products, and the relation of dairy 
consumption to GI-symptoms. The previous history of atopy and hypersensitivity to 
common inhalant and food allergens as well as history of diagnosed gastrointestinal 
diseases (coeliac disease, inflammatory bowel disease, gastric ulcer, Helicobacter pylori 
positivity, cancer of gastrointestinal tract and cholecystectomy); the family history of 
gastrointestinal diseases was also requested. Additionally, we recorded the current weight 
and height of the subjects. The total number of items asked was 24, and additionally it was 
possible to give unstructured information. In order to test the validity and accuracy of the 
questions, the questionnaire was pre-tested among a small number of working-age healthy 
adults. 
4.2.2 Laboratory and functional analyses 
4.2.2.1 Genotyping for C/T-13910 
 
All 1900 blood samples were sent to the Helsinki University, Department of Clinical 
Genetics for analysis of the C/T-13910  genotype of the subjects. DNA of the study subjects 
(n=1900) was isolated from peripheral blood samples. 
The C/T-13910 single nucleotide polymorphism was analysed using the solid-phase 
minisequencing method (Syvänen et al 1990) which is based on the detection of tritium-
labelled T-13910 and C-13910 alleles in the PCR reaction and measurement of their ratio 




4.2.2.2 Analyses for undiagnosed coeliac disease 
 
All 1900 blood samples were analysed for coeliac disease. Tissue transglutaminase 
antibody of IgA class, TG2A was determined for all study subjects. The HLADQ2 and 
DQ8 genotypes, which are the major HLA genotypes associating with CD, (Mäki et al 
2003) were determined in each patient with a TG2A level above the cut-off limit (8 %), 
and in those who reported that they were CD patients. Antiendomysial antibodies of IgA 
class, EmA (Kolho et al 1998) were determined in each TG2A positive case. Total serum 
IgA was determined nephelometrically (Kolho et al 1997; Sulkanen et al 1998). 
Nutritional status was determined by the subjects’ body mass indexes (BMI) and 
measuring iron (S-Fe), transferring receptor (S-TfR), and folate in their serum. The 
established reference ranges were 9-34 umol/l for S-Fe, 0.9-2.3 mg/l for S-TfR and 4.5-34 
nmol/l for folate. The cut-off value for underweight individuals was BMI  <18.5 kg/m2 and 






al 2000). Fourteen subjects who were positive for TG2A and EmA were contacted 




4.2.2.3 Analyses for milk protein IgE 
 
The Pharmacia CAP System was used for screening of specific IgE against major food 
allergens (wheat, codfish, peanut, egg (ovalbumin), soy-bean, cow’s milk) in a total of 857 
subjects. Values equal to or higher than 0.35 IU/l were considered positive. Those with a 
positive total screen were further screened for specific IgE to untreated skimmed milk (f2; 
milk-IgE) and boiled milk-IgE (f231; Pharmacia ImmunoCap System). 
All thirteen individuals with a positive milk-IgE test were invited to an open milk 
challenge test, which was performed in the Skin and Allergy Hospital under strict hospital 
control and surroundings. A total amount of 570 ml of low-lactose and low-fat milk was 
given orally in a 65-minute period and the challengees were followed-up at hospital for 
two hours. The skin reactions and gastrointestinal symptoms were registered. The follow- 
up was continued for a further 24 hours by the subjects. 
 
 
4.2.2.4 Analyses for milk protein IgA and IgG  
 
The milk protein IgG and IgA were measured as described from 400 randomly picked 
samples by ELISA using an adapted infant formula to coat the microtitre plates, and 
values were expressed as % of the standard with a very high titre of cow’s milk antibodies 
(Savilahti et al 1993). The major antigen in the formula was casein. 
    IgG antibodies to Helicobacter pylori were measured from all 1900 participants with an 
in-house enzyme immunoassay as previously described (Oksanen et al 1998). The lower 
limit for raised titres was 700 with a sensitivity of 99% and specificity of 93% as 
compared to histology (Oksanen et al 1998).  
 
4.2.3 Statistical analyses 
Statistical analyses were conducted using Tixel (version 8.1), which is a VBA-programme 
for Excel. Descriptive analyses were conducted with simple logistic regression. 
Proportions were compared by using Chi-squared tests with continuity correction. Also 
Kruskall-Wallis test, Spearman Rank Correlation, Mann-Whitney, Fisher’s exact test, and 







5 Results and discussion 
5.1 Adult-type hypolactasia 
 
In the first study, we evaluated the correlation of the C/T-13910 genotypes with reported 
milk induced GI-symptoms and the clinical usefulness of the human genotype based C/T-
13910 test in diagnosing adult-type hypolactasia. The recessively inherited C/C-13910  
genotype has been shown to correlate with low lactase activity ( <10 Ug/l), whereas the 
C/T-13910 and T /T-13910  genotypes  have been shown to possess a higher lactase activity: 
C/T-13910 genotype > 30 Ug/l and T /T-13910  genotype  >50 Ug/l (Järvelä et al 2005). Adult-
type hypolactasia is the most common enzyme deficiency affecting 17% of the Finnish 
population (Sahi 1994). In this study the prevalence of lactase non-persistence was 18%, 
reconfirming the previous figures of lactase non-persistence in the Finnish population. 
There was no difference in genotype distribution among males and females, or different 
age groups.  
 
The study participants 
Of the subjects giving a blood sample for the study, the response rate to the questionnaires 
was extremely high, 99% (1885/1900). The majority of the participants were women 
(73%), most likely confirming the fact that women are keener to volunteer for different 
types of studies (West et al 2003). It might also imply that women visit health care centre 
laboratories more often than men. However, this female predisposition may somewhat 
bias the results. The total number of laboratory visitors that took part in the study as well 
as the number of subjects who refused to participate was not evaluated; nor the number of 
male or female visitors to the laboratory in the study period. 80% of the participants 
reported having had GI-symptoms in the previous three months, which accords with the 
study of Drossman et al in the American population (Drossman et al 1993). The result 
shows that persons without at least occasional GI-symptoms are a rarity. The implication 
is also that person having GI-symptoms would be more likely to take part in the study, 
which could have a biasing effect on the results. Over 60% of the participants related their 











Figure 2       The self-reported correlations of GI-symptoms to various food substances      


















      
The reason for a laboratory visit was associated with GI-symptoms in only 19% of the 
subjects, and of them 24 % had the C/C-13910  genotype, a higher frequency of hypolactasia 
than in an unselected Finnish population. The connection of GI-symptoms as a reason for 
a laboratory visit and the C/C-13910 genotype was statistically significant compared to the 
persistent genotypes C/T-13910 and T/T-13910. Also the GI-symptoms in the previous three 
months were reported significantly more often in the C/C-13910 genotype group; the 
frequency of GI-symptoms was also higher than in the persistent genotype groups, but this 
difference was not statistically significant. 
Of the GI-symptoms, only flatulence was significantly more frequent in the C/C-13910 
genotype group compared to the lactase persistent groups. This result differs from that of 
Jussila et al 1969, since according to them all the three above-mentioned symptoms are 
more frequent in subjects with hypolactasia. All the three above-mentioned symptoms of 
flatulence, diarrhoea, and bloating were common in the study group, since 40-60% of the 
subjects reported having experienced them in the previous three months. This supports the 
results of Böhmer et al 1996 and 2001, and Hillilä et al 2004 showing the symptoms of 
lactose intolerance as not being different from the ones of functional GI-symptoms.   
     
Cow’s milk consumption as a drink 
Almost half of the study population reported experiencing gastrointestinal symptoms after 
drinking milk (Figure 2), and one fourth of the participants reported symptoms from food 
containing milk.  Only 18% (60/338; P<0.01)) of the subjects with the C/C-13910 genotype 
of adult-type hypolactasia reported drinking milk with meals, which is significantly less 
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T/T-13910 (36%; 236/653; Figure 3). The fat content of the milk was not investigated, but in 
Finland low-fat or fat-free milk are typically consumed among milk-drinkers 
(www.maitojaterveys.fi). Only occasionally is full cream milk consumed as a drink. 




Figure 3       Flow-chart of cow’s milk consumption as a drink in different genotypes 
                     (modified from study No. I) 
 
 



















Only 9% (29/338) with the C/C-13910 genotype of adult-type hypolactasia consumed 
milk daily and reported no symptoms from milk. However, one third (18/60) of the milk 
drinkers with the C/C-13910 genotype did not answer the question about milk-related 
symptoms. Most participants with the C/C-13910 genotype reported GI-problems from milk 
(69%; 190/274) and did not drink milk. The respective number of people with lactase 
persistence genotypes who reported milk-related problems and did not drink milk was 
54% (299/554) for the C/T-13910 genotype and 50% (207/411) for the T/T-13910 genotype. 
The result was statistically not significant, yet implies that people with the C/C-13910 
genotype tend to consume less milk than the two lactase persistent genotypes, which was 
seen among children in the studies of Rasinperä et al 2006. In a recent study among 
Finnish children from childhood to young adulthood, the subjects with the C/C-13910 






milk products did not differ between the persistent and non-persistent genotypes 
(Laaksonen et al 2009). 
Variation in tendency of experiencing GI-symptoms 
The tendency to experience GI-symptoms from milk varies due to several aspects. The 
colonic microbiota is variable (Egert et al 2006) and the individual sensitivity to feel 
distension of the colon and to sense discomfort varies (Vesa et al 1998). The meal content 
also has an important effect on emptying of the stomach, and thereby affects the lactose 
load in the intestine (Martini et al 1988; Vesa et al 1997). Accordingly, the recognition of 
the possible link between milk consumption and abdominal symptoms is not always easy 
(Suarez et al 1995). According to previous studies, subjects having C/T-13910 genotype 
have a lower lactase level than subjects with T/T-13910 genotype (Enattah et al 2002; 
Kuokkanen et al 2003; Rasinperä et al 2004; Enattah et al 2008). In this study the 
consumption of milk, or the subjective milk-related symptoms, did not differ in these two 
persistent genotype groups. 
 Most lactose malabsorbers seem to tolerate small amounts of milk, especially during 
meals (Vesa et al 1996 and 2000). The amount tolerated has in most cases been shown  to 
be 20 g of lactose (Vesa et al 2000). In this study we did not ask the amount of milk the 
individuals are able to consume without having GI-symptoms, but requested what kind of 
dairy products the study subjects consumed, and the possible effects of the products on 
their GI-symptoms. It was notable that even though almost half of the study population 
suspected milk related GI-problems, the consumption of low lactose content milk was 
minimal. 
Cheese caused gastrointestinal symptoms in 11% of the participants according to their 
own judgement: for 17% of those with the C/C-13910 genotype, 10% of those with the C/T-
13910 genotype and 9% of the ones with the T/T-13910 genotype (P < 0.05). This was 
somewhat surprising since cheese loses most of its lactose concentration by ripening (Fox 
et al 1990). Among all participants, 14% experienced symptoms from cereal or bread, and 
37% from ingested fat (Figure 2), and these symptoms were not related to the genotype of 
adult-type hypolactasia.  
 
Comparison of the C/T-13910  gene test to  LTT 
Among the study population, 15% (245/1649) reported having had a positive lactose 
tolerance test (LTT) earlier. A previous, pathological LTT was reported by 19% (64/341) 
of participants with the C/C-13910 genotype, by 10% (89/901) with the C/T-13910, and by 
14% (91/658) with the T/T-13910 genotype. Five out of these 180 subjects with the C/T-13910 
or T/T-13910 genotype with a pathological LTT reported a previously diagnosed possible 
secondary cause for hypolactasia i.e. coeliac disease. An undiagnosed coeliac disease in 
two other participants of these 180 subjects was suggested due to an elevated level of 
transglutaminase antibodies in their sera. The relatively high percentage of subjects with 
either C/T-13910 or T/T-13910 genotype with no secondary cause for hypolactasia having a 
positive LTT imply that LTT, a commonly used method for diagnosis of lactose 
intolerance, produces high numbers of false positive test results, as has been previously 






diagnosis of lactose intolerance, the extent of subjects with the C/C-13910 genotype who 
might have had a negative result for their LTT is not known.  
The cost benefit of the DNA-based gene test to the LTT was evaluated by Piirainen et 
al in 2007. They concluded that compared to the gene test the LTT was ten Euros more 
expensive per patient. Hence not only the specificity, but also the cost benefit is better for 
the C/T-13910  gene test. 
 
Main results 
To conclude the results and discussion of adult-type hypolactasia, the following are the 
main findings that emerged from our study: gastrointestinal symptoms are more common 
among adults with the C/C-13910 genotype of adult-type hypolactasia than among those 
with genotypes of lactase persistence. This was seen even though individuals with the 
C/C-13910 genotype had restricted their milk consumption. Genotyping for C/T-13910 
polymorphism is a practical means for defining adult-type hypolactasia. 
 
5.2 Coeliac disease 
 
Prevalence of coeliac disease 
Among the study group of 1900 subjects, 33 subjects had an elevated TG2A (> 8 units) 
level. One of these subjects had a recent diagnosis of CD, but all the others with an earlier 
diagnosis of coeliac disease were negative for TG2A. We thus detected 32 suspected cases 
of coeliac disease with screening of TG2A. To confirm our suspicion we measured EmA 
titres of these 32 subjects and found 14/32 increased (>1:50) titres. 18/32 subjects with a 
normal EmA titre were excluded from the group of screen-detected coeliacs. All subjects 
in the series had normal IgA values. All 14 screen-detected coeliacs were positive for 
HLADQ2 or HLADQ8 that associate with coeliac disease. 
22/1885 subjects (1%) reported having had a coeliac disease diagnosed earlier. Of 
these, 16 had undergone gastrointestinal biopsy and in 6 cases the information was not 
given. 18/20 (two blood samples were not available) of these cases had either HLADQ2 or 
HLADQ8 genotype. Hence the total prevalence for coeliac disease was 1:53 when the 
screen-detected and all the diagnosed coeliacs were included. This is higher than in any 
earlier published studies dealing with unselected populations (1:133 in Fasano et al 2003; 
1:83 in West et al 2003; 1:67 in Mäki et al 2003 except for Lohi et al 2008, who found the 
prevalence of 2 %). The criteria for a positive diagnosis of coeliac disease were strict since 
elevated titre of both TG2A and EmA was required. This implies that the true prevalence 
of coeliac disease may be even higher. The cohort screened for CD included a 73% 
majority of women probably due to the fact that women are in the majority among 
voluntary screening participants (West et al 2003). Gender-specifically undiagnosed CD 
was detected in 1:116 (12/1391) of the women and 1:255 (2/509) of the men. Previous 
diagnosis of CD was reported among 1:77 (18/1391) of the women and 1:127 (4/509) of 
the men, ending up in a total prevalence of 1:46 for CD in women and 1:85 for men. 






2005), which was also the case in our study. However, there are several reports showing 
no sex difference in the prevalence of CD (Hin et al 1999; Cook et al 2000; Collin et al 
2002). 
The 14 screen-detected undiagnosed CD patients were personally contacted by the 
author. 6/14 reported having milk related GI-symptoms, and only one considered cereal as 
being causative of her GI-symptoms. Ten patients were willing to undergo gastrointestinal 
biopsy. The biopsy was positive in 8 subjects, the result was not available in two subjects, 
one person refused further investigations, and one person was unsure about undergoing 
gastroscopy. Two patients could not be reached. Thus the findings in biopsies were 
consistent with the positive serum screening, and confirmed the diagnosis of CD. 
 
Comparison of screen detected and previously diagnosed coeliacs 
The BMIs of the screen-detected coeliacs were compared to the ones with a previous 
diagnosis of coeliac disease on a gluten-free diet. The mean BMI of the screen-detected 
coeliacs was 27.1 (range 20.1-41.5), which did not differ from the ones with previously 
diagnosed CD (mean 24.2; range 17.9-32.0). One female with an established diagnosis of 
CD was found to be underweight. A total of 7/14 screen-detected patients were overweight 
(four of them were obese), and 9/21 with a known CD were overweight (two cases were 
obese). The difference in the number of overweight subjects between these two groups 
was not significant. However, one third of the screen-detected CD patients were also 
obese. There is little data on obesity in CD (Oso et al 2006). It is important to note that a 
significant number of screen-detected patients are of normal weight or even overweight, 
and not underweight (Cook et al 2000; West et al 2000; Haapalahti et al 2005). 
The indication for blood sampling was a health check-up at primary care centres in the 
majority of patients with undiagnosed CD (9/14). In two cases the reason was abdominal 
complaints, the main symptoms being flatulence and diarrhoea. Three responders (3/14) 
reported abdominal symptoms on eating cereals. This might suggest that self-experienced 
symptoms are vague in the majority. Milk consumption did not differ between those with 
a previous diagnosis of CD (no milk 19/22) or undiagnosed CD (no milk 9/14) 
significantly showing the majority in both groups to be non-milk drinkers. Those with a 
previous diagnosis of CD reported more heartburn than those with an undiagnosed CD, 
but no further difference in the other gastrointestinal symptoms was discovered. 
Adult type hypolactasia based on a lactose tolerance test had been diagnosed in one 
screen-detected subject. One patient reported a previous suspicion of CD, but there had 
been no definite diagnosis and no follow-up. Of the screen-detected CD patients, only 7 
subjects reported a concomitant diagnosis of another chronic disease. Among relatives of 
the screen-detected CD patients, one person reported having a mother with CD. 
 
Undiagnosed CD may be associated with a lack of nutrients 
Nutritional deficiencies were observed in 50% of the screen-detected CD patients; 
especially the levels of iron and folate in serum were lower when compared to those with a 
previous diagnosis of CD and on a gluten-free diet (Table 3). A deficiency in iron was 
rare, contradictory to symptomatic adult patients with CD (Collin et al 2005). The earlier 






2003) is in line with the findings of this study. Serum folate was below the established 
reference range in half of the screen-detected CD patients, which might imply a subtotal 
villous atrophy (Kemppainen et al 1998). Blood haemoglobin or serum calcium was not 
analysed. 
In screen-detected children with CD, nutritional impairments such as a decrease in 
serum folate level and indicative findings for iron deficiency, were present in one third of 
the study subjects (Haapalahti et al 2005). This is less frequent than present adult study 
shows. Undiagnosed CD may predispose to impaired bone density (Mustalahti et al 2001); 
it might also be associated with a lack of other nutrients such as zinc (Kemppainen et al 
1998; Viljamaa et al 2005), and vitamin B12 (Dahele et al 2001). Likewise, undiagnosed 
CD may be associated with fatigue and other unspecific symptoms even in the absence of 
nutritional impairments (Hin et al 1999; Sanders et al 2003). But the presence of such 





































Table 3      Comparison of nutritional parameters of screen-detected and previously   
                  diagnosed coeliacs 
 
 
Diagnosis Coeliac disease 
Gluten-free diet  
Screen-detected  
coeliac disease  
Gender  
(male/female) 














(20.1-41.5)   
0/4 
S-Fe below the  
reference range  
< 9 umol/l   
 
1/21 2/9 
S-TfR above the  
reference range  
> 2.3 mg/l 
 
0/21 1/9 
S-Folate below the 








Undiagnosed coeliac disease was found to be even more common than earlier studies had 
shown, probably due to the over representation of females among the adult population 
undergoing screening. Nutritional deficiencies were present in half of the screen-detected 
patients even though the great majority considered themselves to be healthy. Nutritional 
impairments were mild, a decline in serum folate levels being the most common. 
There was though, no clear correlation between the GI-symptoms or the BMI and 
undiagnosed coeliac disease. However, the result showing nutritional impairments in 
every other screen-detected CD patient suggests that screening for CD should be actively 
implemented for the working-age population. A further, more recent study from Finland 






for coeliac disease in order to prevent gradual mucous villous destruction (Kurppa et al 
2008). Long-term dietary compliance and the quality of life is good among screen-
detected CD adults (Viljamaa et al 2005), which also encourages screening for coeliac 
disease in risk groups. 
 
 
5.3 Hypersensitivity to cow’s milk 
 
This section of the study focused on milk protein IgE, IgA and IgG mediated reactions to 
milk in an adult population. Due to the large number of study subjects (1900), two 
different sub-groups were formed from the original study group. Hence the results of the 
IgG/A and IgE groups must be evaluated separately. 
5.3.1 Milk protein IgE 
When analysing milk protein IgE, it was found that 1.5 % (13/857) of the previously 
described study group had an elevated milk protein IgE value (>0.35 IU/l). In women, the 
percentage of positive reactions to milk-IgE was 1.3% (9/673), and in men 2.2% (4/184). 
However, the difference was not statistically significant. All milk protein IgE positive 
subjects belonged to the age group of 35-49 years. Milk-IgE for boiled milk was positive 
in 3 subjects, one of them being negative for standard milk-IgE antibodies. 
 No correlation was found with milk drinking and IgE antibodies for milk. The 
prevalence of milk-IgE was not statistically different between those with milk-related 
symptoms and those with no such symptoms (1.6% / 1 %). Those reporting no milk-
related problems used milk as a drink more often (58/101; p<0.001).  Only one subject 
positive for cow’s milk-IgE antibodies reported no milk-related symptoms. 
 
An open food challenge 
All 13 milk-IgE positive adults were contacted by phone, and all 9 who could be traced 
accepted the invitation to a cow’s milk challenge test. The aim was to test the clinical 
relevance of milk-IgE positivity by performing a food challenge with milk. In addition, the 
subject negative for milk-IgE, but positive for boiled milk- IgE agreed to testing. Thus, ten 
subjects in all took part in the food challenge. These subjects had reported milk-related 
GI-symptoms except for one person. An open milk challenge was arranged at the Skin and 
Allergy Hospital of Helsinki University. All subjects experienced abdominal discomfort 
and bloating during the ingestion of 570 ml of milk. One subject reported diarrhoea 
immediately after the ingestion, but none of the subjects developed skin symptoms. The 
open protocol used in the milk challenge test may have had a psychological impact on the 
prevalence of abdominal symptoms. The decision to challenge only the subjects with an 
elevated concentration of milk-protein IgE, and not to include milk-protein IgE negative 






only in those with IgE antibodies to the challenged food allergen (Sampson 2001; Ewan et 
al 2005; Mansueto et al 2006). A control group with no IgE antibodies would not have 
changed the negative results of the challenge test.  
The milk challenge was performed with low lactose  milk to avoid symptoms related to 
lactose malabsorption. One subject with the genotype C/C-13910 associated with low 
lactase level developed diarrhoea immediately after the milk ingestion, and the reaction 
was thus considered hypolactic rather than allergic.  
 
Atopy and milk protein IgE 
A prior screening for atopy was reported by 36/46 (78%) of those with a positive food-
screen. 26/36 (72%) had received a positive diagnosis either with skin prick tests or with a 
blood screen. Among those with a positive test result for milk-IgE antibodies, a previous 
diagnosis of allergy to animals or pollen was reported by 6/13 (46%). In the total study 
population, a previous diagnosis of atopy based on skin prick testing or RAST screening 
was reported by as many as 42% (349/857) of the subjects. The testing had been done 
either in childhood (n=129;37%), or at an adult age (n = 162;46%). 52 subjects (15%) had 
been tested positive  for atopy, both in childhood and adulthood. 6 subjects ( 2%) did not 
report this information. 
     It is notable that IgE antibody levels for various food allergens reflect dietary habits 
(Schafer et al 2001; Jun et al 2006). Although dairy consumption in Finland is high 
(Järvelä 2005), the IgE levels for cow’s milk protein in the present study were low 
compared to earlier studies (Sampson et al 2001; Sicherer et al 2006). Consumption of 
milk as a daily drink was not associated with a positive test result for IgE antibodies 
against cow’s milk. A large number of those with a positive screen for major food 
allergens reported a previous, test-confirmed, positive diagnosis of atopy. Although the 
subjects were not tested for atopy, this implies a link between atopy and the presence of 
IgE antibodies for food antigens. It has been shown that atopic individuals are more prone 
to food hypersensitivity (Bjornsson et al 1996; Schafer et al 2001; Mattila et al 2003). A 
recent report from Finland shows that in school-aged atopic individuals, IgE antibodies to 
milk are common (Kolho et al 2005). Furthermore, the inhalant IgE antibody levels in the 
younger age cohorts have increased during recent years (Park et al 2006), so it was 
surprising that the number of positive results for IgE antibodies for food was not bigger 
among the youngest (18-33 years) than the oldest age group (50-64 years). However, the 
ethiopathogenesis of the presence of low IgE levels for food antigens in adults is obscure.  
 
Main results 
Low levels of food-specific IgE, for example for milk, do occur in adults, but a positive 
antibody level is seldom related to objective symptoms of hypersensitivity; hence 








5.3.2 Milk protein IgA and IgG 
In this study, a randomly-selected group of 400 subjects (from the original group of 1900) 
was evaluated. The evaluation showed that subjects drinking milk had higher levels of 
milk protein IgG in their sera than non-milk drinkers (p < 0.001), supporting the view that 
the presence of milk protein IgG specific antibodies may, to a certain degree, be a normal 
physiologic reaction to ingested milk protein. There was a positive correlation with milk-
related GI-symptoms and milk protein IgG level: subjects reporting gastrointestinal 
problems after drinking milk had higher milk protein IgG levels, but consumed less milk 
than those who experienced no GI-symptoms. Dyspeptic subjects had lower milk protein 
IgG level than non-dyspeptics (p < 0.05). The association of high milk protein IgG level 
with constipation was close to the level of statistical significance. Diarrhoea had no 
association with milk protein IgG level (p = 0.5). Of minor symptoms, flatulence and 
bloating (p = 0.8), were not associated with milk protein IgG level.  Milk protein IgA 
levels did not show any correlation to drinking milk. The frequency of specific GI-
symptoms was not requested. 
The levels of milk protein IgA and IgG declined as the age of the subjects increased, 
being lowest in the oldest age group; the age-related decline being statistically significant 
with milk protein IgG (p < 0.004). The age and personally estimated milk-related 
gastrointestinal problems had no correlation (p = ns). Men had higher milk protein IgA 
level in their sera than women (p = 0.04), but milk protein IgG level had no statistical 
significance gender-specifically.  
 
Milk protein IgG or IgA and correlation with other inducers of GI-symptoms  
Milk protein IgG was lower in subjects positive for antibodies to Helicobacter pylori 
(n=76/386, p < 0.05), although they drank milk more often than Helicobacter pylori 
negative subjects (n= 62/76, p < 0.006). However, the Helicobacter pylori positive group 
was somewhat older (mean age 46 years) than the Helicobacter pylori negative group 
(mean age 40 years, p = 0.004), which may explain the result. Furthermore, only 24/ 129 
dyspeptic subjects were positive for Helicobacter pylori antibodies, showing that the  
negative correlation of IgG level with dyspepsia and Helicobacter pylori positivity are 
independent results. Accordingly, the presence of Helicobacter pylori antibodies in serum 
was associated statistically significantly to a lower level of milk protein IgA antibodies (p 
= 0.03)  
There was no correlation between milk proteins IgG or IgA, and C/T-13910 genotype 
associated with adult type hypolactasia. Surprisingly, none of these subjects was screen-
positive for coeliac disease (Study No. II). There was no correlation with milk specific 
IgG or IgA to a reported history of a diagnosed gastrointestinal disorder (irritable bowel 
syndrome n = 12/388 (3.0%) or inflammatory bowel disease n = 4/388 (1.0%)), since none 
of those patients had high levels of cow’s milk specific IgG or IgA. Irritable bowel 
syndrome was reported less in the study group than in an average Western population (5-
10%), and inflammatory bowel disease more often than in an average Western population 







Milk protein IgG or IgA and clinical usefulness 
There are studies showing that IgG4, which is a subgroup of IgG, might be useful in ruling 
out food intolerance due to its high negative predictive value (Bernardi et al 2008). Yet 
several others have shown no clear correlation between food intolerance and food specific 
IgG. Skripak et al showed that by sensitising cow’s milk allergic children orally with milk 
there was an increase in milk specific IgG, especially in milk IgG4, but the milk specific 
IgE level did not change significantly (Skripak et al 2008). A positive correlation of a high 
level of food specific IgG4 in infancy and tolerance to corresponding food later in life has 
been shown (Tomicic et al 2009). A recent study from India (Poddar et al 2008) showed 
no correlation of cow’s milk protein intolerance and the IgG anti-lactoglobulin antibody 
test, and recommended not using it in diagnosing cow’s milk protein intolerance. Sletten 
et al showed a decrease in casein-specific IgE, IgG1 and IgG4 both in IgE-mediated and 
non-IgE-mediated CMA patients, whereas casein-specific IgA remains unchanged (Sletten 
et al 2007). A Dutch study showed that maintenance of tolerance in atopic children and 
adults to cow’s milk in atopic children and adults without CMA was associated with 
elevated levels of milk-specific IgG4 in combination with low specific IgE (Ruiter et al 
2007). There is also a recent study from Italy (Volpi et al 2009) showing that IgG could be 
used as a useful indicator of adverse reactions to food and food hypersensitivity. The 
clinical usefulness of the milk-specific IgG and its subgroups is still controversial, and 





Milk protein IgG correlates with self reported milk-related GI-symptoms, whereas milk 
protein IgA has no such correlation. Milk protein IgG also correlates with drinking milk. 
This implies that milk protein specific IgG has a role in humoral reaction to ingested milk. 
However the measurement of milk protein IgG provides no accurate information on milk 
hypersensitivity. 
 
5.3.3 How to approach GI-symptoms related to milk in adults in primary care 
The approach to milk related symptoms in an outpatient clinic is best done systematically 
by eliminating possible primary and secondary reasons with screening, and by setting a 















































































6 Conclusion and future prospects 
This study was large, and the goal to evaluate adult type food and especially milk- related 
symptoms and their correlation to specific screening methods in an outpatient setting was 
challenging. The seasonal variation was eliminated as we managed to collect all samples 
during a three-month period. Furthermore, the 99% response rate to the questionnaire was 
exceptionally high. This shows that people are interested in taking part in studies 
concerning their well-being, and even more when they receive valuable information which 
might help in resolving their possible health problems. Gastrointestinal symptoms are a 
common cause of diminished well-being and hence the participation rate of this study was 
excellent. Nevertheless, there are some confounding factors in this study which can bias 
the results: self-reported answers can have an effect on the results, since people’s 
recollections are often not accurate, and the questions might be interpreted in various 
ways. However, the questionnaire was pretested on a small group of adults and its 
legibility and clearness were adjusted as well as possible. Since the participants were 
working-age persons, capable of understanding the questions, we can trust the answers to 
be accurate. Furthermore, the majority of participants were women, which can also 
somewhat bias the results. Since the prevalence of adult type hypolactasia was similar in 
this study group to previous studies in the Finnish population, it may be concluded that the 
study group represents the average Finnish population well. 
 Firstly, the question was set whether a gene-based test for adult type hypolactasia is 
applicable in clinical practice, and whether it should be used when diagnosing food and 
especially milk-related symptoms. And with no doubt the answer is yes. This test easily 
provides valuable and reliable information with a lifelong validity, and correlates well 
with the symptoms caused by adult type hypolactasia. The lactose tolerance test should no 
longer be used as a screening method of primary hypolactasia, due to its poor sensitivity 
and specificity as well as its relatively high cost and time consumption. 
The second question was whether coeliac disease should actively be screened with 
new, easily accessible, and reliable non-invasive tests. The answer to this is also positive. 
The prevalence of undiagnosed coeliac disease is higher than previously thought. The 
symptoms of coeliac disease can be various. Besides gastrointestinal symptoms, there are 
numerous reports of different types of problems related to coeliac disease. Since the 
measurement of EmA or TG2A in association with IgA is easy and reasonably priced, this 
method should be used in outpatient clinics. However, a positive test result should be 
verified with gastroscopy and jejunal biopsy in accordance with current good clinical 
practice. The gluten-free diet is currently recommended if there are changes typical for 
coeliac disease in small bowel mucosa. It is yet to be seen whether future nutritional 
guidance might rely on non-invasive methods only. 
The answer to the third question whether milk protein specific antibodies of group 
IgA, IgG or IgE should be measured among adults in diagnosing milk hypersensitivity in 
adults, is no. Their benefit to clinical judgement and diagnosing is, according to current 
knowledge, negative. Measurement of IgE with RAST-method is justified in atopy, even 
though prick testing gives more accurate results in most cases. In food related 






information since low levels of food specific IgE are relatively common, and they do not 
correlate to the symptoms. Milk specific IgG is most likely a physiological reaction, 
although milk protein IgG level showed a positive correlation to self-reported milk related 
gastrointestinal problems in this study. Milk protein IgA does not seem to correlate with 
possible milk related problems. Furthermore, both milk protein IgG and IgA levels 
decreased towards older age groups in the study, the meaning of which is unclear. 
The roles of milk protein IgA and IgG subgroups have also been studied, but the 
findings do not seem to give any further information; however, the milk protein IgG4 in 
milk hypersensitivity might have a role in the future. Milk protein IgE does not play an 
active role in milk induced gastrointestinal hypersensitivity in adults. Current belief is that 
a not yet characterized immunological type process might be behind the symptoms. The 
symptoms of food hypersensitivity are expressed individually also due to variation of 
bacterial flora in the colon, and due to individual sensitivity to feel distension in the colon 
as previously described. Also other food substances consumed (e.g. rye bread) might 
simultaneously be a reason for the symptoms. 
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